Glivec Imatinib Mesylate
Glivec Imatinib Mesylate Tablet 100 mg (100 mg) — certified targeted therapy from Meridian Medicine Pharma. Available for bulk pharmaceutical export.
100 mg
Glivec Imatinib Mesylate 100 mg
10 Tablets per strip
Meridian Medicine Pharma
Pricing and availability are confirmed by our team after checking the product, quantity, destination rules, and required documentation.
Bulk quotes, documentation, and shipping options are handled manually after prescription, buyer, and destination checks where applicable.
Manufactured by Meridian Medicine Pharma, Glivec Imatinib Mesylate Tablet 100 mg is a pharmaceutical-grade targeted therapy product containing Glivec Imatinib Mesylate 100 mg. The active ingredient functions as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity, making it effective for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This product is produced under strict GMP conditions with complete batch traceability. Export-ready with Certificate of Analysis, stability data, and documentation required for international pharmaceutical import.